| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.0M | -12.2% |
| R&D Expense | $673K | -22.2% |
| SG&A Expense | $31.1M | +132.6% |
| Operating Income | -$39.1M | -67.6% |
| Interest Expense | $287K | +320.3% |
| Pre-tax Income | -$35.2M | -52.9% |
| Income Tax | -$537K | -26.1% |
| Net Income | -$32.8M | -95.7% |
| EPS (Basic) | -$0.83 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.8M | -80.0% |
| Short-term Investments | $37.7M | +328.0% |
| Accounts Receivable | $492K | -30.6% |
| Current Assets | $76.8M | -19.0% |
| Total Assets | $89.8M | -20.3% |
| Current Liabilities | $49.6M | +62.7% |
| Total Liabilities | $52.1M | +48.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | -0.2% |
| Capital Expenditures | $118K | +42.8% |
| Investing Cash Flow | -$38.4M | -261.3% |
| Financing Cash Flow | $801K | -96.7% |
| Free Cash Flow | -$9.9M | -0.5% |
| -97.6% |
| EPS (Diluted) | -$0.83 | -97.6% |
| Stockholders' Equity |
| $34.8M |
| -52.4% |